CVS Hits KV With $100M Claim Over Recalled Drugs

Law360, New York (March 1, 2010, 3:00 PM EST) -- CVS Pharmacy Inc. has sued KV Pharmaceutical Co. and subsidiary Ethex Corp. for allegedly failing to supply certain generic drugs after regulators recalled them, which the drugstore chain estimates cost it $100 million over the past year.

CVS Pharmacy, a unit of CVS Caremark Corp., filed suit against KV and its nonbranded and generic unit Ethex on Friday in the U.S. District Court for the District of Rhode Island, asserting claims for breach of contract and breach of the implied covenant of good faith and fair...
To view the full article, register now.